Author of

• 16935

  +

  P1.08 - Poster Session with Presenters Present (ID 460)

  • Event: WCLC 2016
  • Type: Poster Presenters Present
  • Track: Surgery
  • Presentations: 1
  • Moderators:
  • Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)

  • 16950

    +

    P1.08-015 - Surgery of Stage I Non-Small Cell Lung Cancer in Patients Aged 80 Years or Older (ID 3921)

    14:30 - 14:30  |  Author(s): O. Kawamata
    • Abstract
    • Slides

    Background:
    Non-small cell lung cancer (NSCLC) is a typical disease of the elderly patients, and is becoming increasingly. Surgical resection is standard treatment for early-stage NSCLC. We evaluate the efficacy of lobectomy versus segmentectomy for stage I non- small cell lung cancer in elderly patients 80 years or older.
    
    Methods:
    54 cases with stage I of 82 patients aged 80 years or older who underwent surgery for non-small cell lung cancer at our hospital between 2004 and 2013 were studied. The patients’ medical records were reviewed with type of operation, histological diagnosis, postoperative morbidity, postoperative mortality and survival results.
    
    Results:
    There were 33 men and 21 women. The average ages were 83.4 years (range, 80-90 years). Adenocarcinoma was identified in 45 patients and squamous cell carcinoma was identified 9 patients. Lobectomy was performed in 25 patients for stage IA (n=10) and IB (n=15), segmentectomy was performed in 18 patients for stage IA (n=15) and IB (n=3) and wedge resection was performed in 11 patients for stage IA (n=10) and IB (n=1). Mean follow-up was 53 months. 4 cases of 54 patients died for lung cancer and 8 cases died for other causes within 5 years after lung resection. Overall survival rate at 5 years in all patients was 70.6%. One case of 25 patients who underwent lobectomy died for lung cancer (IA n=1, IB n=0). 3 cases died for other causes (IA n=1, IB n=2). Two cases of 18 patients who underwent segmentectomy died for lung cancer (IA n=0, IB n=2), 3 cases died for other causes (IA n=2, IB n=1). Overall survival rate at 5 years for lovectomy vs segmentectomy was 74.5% vs 68.1% (IA; 67.5% vs 86.7%, IB; 77.0% vs 0%). Morbidity rate in all patients was 22.2% (lobectomy; 20.0% vs segmentectomy; 27.8%), atrial fibrillation 5 patients (3 vs 2), heart failure 1 patient (0 vs 1), prolonged air leakage 3 patients (1 vs 2), atelectasis 2 patients (0 vs 2), delirium 1 patient (1 vs 0). Mortality rate was 0% in both groups.
    
    Conclusion:
    The lobectomy and segmentectomy were equal results in elderly patients 80 years or older for stage IA NSCLC. These data further support the use of lobectomy for resection of stage IB tumors.
    
    

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.